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Development and differentiation could be mediated by continuous changes of 
cell  surface glycoconjugates through  which cell-cell interaction  may take place 
(1).  Rapid,  dramatic  changes  of specific  carbohydrate  structures  defined  by 
various antibodies during the development of the preimplantation  (2-1 I) as well 
as the postimplantation (12) mouse embryo have suggested that these structures 
are signals for cell recognition.  Despite the fact that a great deal of information 
has accumulated  on  cell surface  carbohydrate  changes during  mouse embryo- 
genesis, our knowledge of the cell surface glycoconjugates in human embryos is 
extremely  meager.  Only  one  series  of studies  by Szulman  (13)  indicates  the 
occurrence of an  orderly appearance  and disappearance  of blood group A,  H, 
and  Lewis antigens  during  human  embryogenesis.  A  systematic knowledge  of 
the changes of cell surface carbohydrates during organogenesis is important for 
understanding  tbe oncofetal expression of tumor-associated antigens  expressed 
in many human cancers. A series of glycolipids bearing the X determinant  have 
been found to be accumulated in various types of human adenocarcinoma, and 
their structures bave been identified as shown in Table I. A number of monoclo- 
nal  antibodies  produced  by various  investigators,  originally  assigned  as  being 
directed to "tumor-specific antigens",  have been identified as being directed to 
the  same  structure  as an  embryonic antigen,  SSEA-1  (14-16).  The  glycolipid 
lactofucopentaosyl(III)ceramide,  designated as X  hapten  (17),  was found to be 
greatly  accumulated  in  various  types of human  cancer  (18) and  has  the  same 
terminal  structure  as  SSEA-1.  However,  the  antigen  defined  by the  SSEA-1 
antibody is widely distributed in normal  human  tissues, such as gastric epithelia 
and  kidney tubules, as well as in a  large variety of tumors (19).  More recently, 
glycolipids  with  di-  or  trimeric  X  determinant,  difucosyllactonorhexa- 
osylceramide  (III3V3Fuc2nLc6)  and  trifucosyllactonoroctaosylceramide  (III3V ~- 
VII~Fuc3nLcs), have been found to accumulate in colonic and liver cancers (20). 
Two monoclonal antibodies have been established; one antibody, FH4, is directed 
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TAaLE  I 
Reactivity of FH3 and FH4 to Fucosylated Type 2 Chain Structures 
507 
Reactivities with: 
Antibodies  Ig class 
II13FucnLc4  *  VSFucnLc6  *  III3V3Fuc~nLc6  ~  IlI3V3VII3Fuc3nLcs  ! 
FH3  lgG3  +  +  +  + 
FH4  IgG3  -  -  +  + 
* Gal/31  ~  4GlcNAcl31  ---* 3Gall31  ~  4GIc~l  ~  1Cer 
3 
T 
Fucal 
* Gall31  ~  4GlcNAc/31  ~  3Gall31  ~  4GIcNAc/31  ~  3Gal/31  ~  4Glcl31  ~  ICer 
3 
T 
Fuccd 
0 GalS1  --~ 4GIcNAcI31 ~  3Gall31  ~  4GlcNAcOl  ~  3Gall31  ~  4Gic/31  ~  1Cer 
3  3 
Fucc~ 1  Fuca 1 
I Gal/31  ~  4GIcNAcI31  ~  3Gal~l  ~  4GIcNAc~l  ~  3Gall31  --~ 4GIcNAcl31 ~  3Gall31  ~  4G1c131 ---* 1Cer 
3  3  3 
T  T 
Fuca 1  Fuca 1  Fuca 1 
towards di- or trifucosylated type 2 chains, and the other, FH3, is directed toward 
the X  determinant as the common terminus of various fucosylated type 2 chains 
(21).  Because it was noticed (21) that di- or trifucosylated type 2 chains defined 
by antibody FH4 were much more restricted than the X hapten structure defined 
by FH3 and  because both FH3 and  FH4 antibodies are IgG3  with comparable 
reactivities, a systematic study of the distribution of the antigens defined by these 
two antibodies  in  various stages of human  development was  undertaken  using 
immunohistological techniques. 
Materials and  Methods 
Tissues.  27  human  embryos and  fetuses  ~ were collected at  the  Division  of Human 
Embryology and Teratology, Department of Pediatrics, University of Washington. The 
ages of the embryos and fetuses were between  38 and  127  d,  and  were organized as 
described by Shepard et al.  (22).  Two newborn tissue samples were donated from the 
Department of Pathology, Children's Orthopedic Hospital, Seattle. Various normal adult 
tissues,  including colon,  stomach,  ovary, lung,  skin,  breast,  liver,  spleen,  and  skeletal 
muscle, were obtained from specimens associated with the surgical removal of tumors. In 
total, 65 cases of various cancer tissues  were obtained from the Department of Surgery, 
Swedish  Hospital,  Seattle,  and  from Japan  hnmunoresearch  Laboratories,  Takasaki, 
Japan. Formalin-fixed, paraffin-embedded sections of normal bladder, urethra, and testis 
were obtained from the Department of Urology, Tohoku University School of Medicine, 
Sendal, Japan. 
Antibodies.  lgG3 monoclonal antibodies FH3 and FH4 (21) were purified from culture 
supernatant or from ascites fluid by affinity chromatography on a protein A-Sepharose 
According to the definition of Moore (26), the time from  1 to 8  wk after fertilization  is called 
the  embryonic period,  and  9-38  wk  is  called  the  fetal  period.  The  terms embryo and  fetus are 
approximately distinguished according to this definition. 508  FUCOSYL  TYPE  2  CHAIN  IN  HUMAN EMBRYO AND CANCER 
column. Antibody adsorbed on protein A-Sepharose was eluted with 0.1  M citrate buffer, 
pH 4.2, dialyzed against phosphate-buffered saline  (PBS), 2 and stabilized  by addition of 
0.1% bovine serum albumin. The final concentration of antibody was adjusted to 100 #g/ 
ml,  which was approximately equivalent to a  sixfold  dilution of ascites.  The secondary 
antibody (rabbit  Ig directed  to mouse Ig) conjugated with  horseradish  peroxidase  was 
purchased from Accurate Chemicals Co., Westbury, NY. 
Preparation of Tissue Sections.  Tissues were embedded in OCT compound (Tissue-Tek 
II Division, Miles Laboratories, Inc., Naperville, IL), frozen in dry ice-acetone, and stored 
in a Revco freezer at -80°C until use. Frozen sections  (4-6/tm thick)  were prepared on 
a  cryostat.  Each section  was dried on objective glass for 30 min at room temperature, 
fixed in acetone at 4°C for 10 rain,  and washed with  PBS at 4°C. Tissue sections  (6-8 
#m thick) were also prepared from formalin-fixed, paraffin-embedded specimens accord- 
ing to established  procedure. Sections were deparaffinized in xylene for 5 min at 4°C, 
dehydrated in ethanol, and washed with  PBS.  Before antibody labeling,  frozen sections 
and  paraffin-embedded sections  were  blocked by  incubation  with  15%  normal  rabbit 
serum in PBS for 1 h at room temperature. 
lmmunostaining Procedure.  After blocking with  normal  rabbit  serum,  sections  were 
incubated at  room temperature  with  the  primary antibody solution (FH3 and  FH4  as 
prepared above) for 18 h in a moist chamber. Sections were washed three times with PBS 
at 4°C (5 min per washing).  Sections were then incubated with the peroxidase-conjugated 
second antibody (diluted  1:30)  for  1 h  at  room temperature  in  a  moist chamber and 
washed three times in PBS at 4°C as above. Bound antibodies were detected by incubating 
tissue  sections in 0.05 M Tris/HCl buffer, pH 7.6, containing 0.03% 3,3'-diaminobenzi- 
dine (Sigma Chemical Co., St. Louis, MO) and 0.008% hydrogen peroxide. After 10 min, 
the sections were  washed with  distilled  water,  counter-stained with  hematoxylin, dehy- 
drated in ethanol, washed with  xylene, and mounted. Two controls were performed for 
each  staining  experiment:  sections  treated  without  the  primary antibody and  sections 
treated with  normal mouse serum. Specific  tissue  labeling was not observed after either 
of the above treatments. 
Comparison of  lmmunostaining of  Frozen Sections and Paraffin-embedded Sections.  In view 
of a possible  deletion of glycolipid antigens during preparation of sections from paraffin- 
embedded specimens, staining of the antigens in these sections  was carefully compared 
with  cryostat  sections  from  frozen  samples.  There  were  no  significant  differences  in 
immunoreactivity between frozen sections and paraffin sections for both fetal and newborn 
specimens. 
Results 
General Developmental Changes of Antigens Defined by FH3 and 
FH4 Antibodies 
Strong staining of embryonic and fetal tissue by both FH3 and FH4 antibodies 
was  limited  to  gastrointestinal  and  urogenital  epithelia, 3 and  the  patterns  of 
antibody  reactivity  showed  dramatic  changes  depending  on  the  stage  of the 
embryo.  The  X  determinant  defined  by  the  FH3  antibody  showed  a  wider 
distribution  than  the multimeric X  antigen  defined by the  FH4 antibody. Both 
antigens  were  absent  or  present  in  relatively  low  concentration  during  early 
embryonic  development  (up  to  40-50  d),  showed  maximum  expression  at  a 
specific  stage  of development  (mostly  50-70  d),  and  regressed  upon  further 
differentiation and development. The antigen  defined by FH3 appeared about 
2  Abbreviations used in this paper: PBS, phosphate-buffered saline (10 mM sodium phosphate buffer, 
pH 7.2, containing 0.9% NaCI). 
Since the staining behavior and its change in urogenital epithelia associated with development 
fi'om pronephros through  metanephros are highly complex, and since there was a great deal of 
variation in the staining of a variety of kidney tumors, this subject will be described elsewhere. T
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TABLE  Ili 
Reactivities of Circulatory,  Respiratory  Organs, Adrenal, Skin, and Nervous System of Human 
Embryo with FH3 and FH4 Antibodies 
Anti- 
bod~  Organ 
i  __ 
Heart, artery and vein  -  - 
Lung airway 
Trachea 
FH3  Cerebrum, cerebellum 
and pons 
Spinal cord 
Adrenal 
Spleen 
Skin  +1  +! 
Bone and Muscle  -  -  - 
Heart, artery and vein  -  -  - 
Lung airway 
Trachea 
FH4  Cerebrum, cerebellum 
and pons 
Spinal cord 
Adrenal 
Spleen 
Skin  +! 
Bone and muscle  -  -  - 
*  Adrenal  cortex,  -;  medulla,  4,. 
Adrenal cortex, -; medulla,  +. 
|  Entire layers of skin, +. 
I  Duct of eerine sweat gland, 4-; epidermis, +; eorium,  -. 
!  Entire  layer,  -. 
Stage of embryo  in gestation  days) 
,~  2~53  __  r  38  40  54  58  ~  64  67  69  72  84  ll0  127 
P  F  F  P  F  P  P  P  P  F  F  P  F  P  P  P 
+  4-  --  --  --  4.  4, 
+  + 
-  -,±*  -,±*  -,4,*  -,+*  -,4-* 
+i  +! 
i 
-  -,+*  -,4-*  -+* 
+|  +f  +f 
_,+~t  I_±, 
-,+*  -,_.* 
-,+*  -,~* 
Newborn 
P  F 
+ 
--+T 
+1 
--,_+* 
1 
2  wk  earlier  than  the  antigen  defined  by  FH4  and  regressed  later  than  that 
defined  by  FH4  or  was  continuously  expressed  after  birth.  Thus,  the  FH4 
antigen was often limited to a specific type of cell in certain epithelial tissues (see 
below). The reactivities of the FH3 and FH4 antibodies with fetal, newborn, and 
adult tissues are summarized in Tables ]I, III, and IV. 
Weak  staining  was  also  observed  in  the  pulmobronchial  epithelia,  adrenal 
medulla, and entire layers of the epidermis by both FH3 and FH4 in embryonic 
stages. The reactivities of FH4 regressed completely in newborn tissues. A  weak 
staining  with  FH3  remained,  however,  in  the  adrenal  medulla  as  well  as  in 
sebaceous and sweat glands of the epidermis (Table III). 
The  antigens  recognized  by  FH3  and  FH4  were  not  found  in  connective 
tissues, nervous tissues (brain and spinal cord),  tissues of the circulatory system 
(beart,  arteries,  and veins),  skeletal  tissue (bones and muscles),  or other paren- 
chymatous  organs,  such  as  liver  and  spleen,  at  any  stage  of  development. 
Distribution of the antigen defined by FH4 in tissues of newborns and adults was 
limited to specific types of cells in gastric and intestinal epithelia and the antigen 
was completely absent in colonic epithelia. FUKUSH1  ET  AL.  511 
TABLE  IV 
Reactivities of Human Adult Tissues with FH4 Antibody 
Tissue 
Reactivity (number  of cases) 
Paraffin  Frozen 
section  section 
Stomach 
Surface  mucous  cells  -,+*  ± 
Chief cells  -  - 
Parietal cells  ++  (4)  +  (3) 
Pyrolic gland  ++  + 
Other  cells  -,+*  ± 
Small intestine 
Paneth's  cells  ++  ++ 
Basal granular  cell  ++  ++ 
Cuticular  or brush  border  cells  -  (2)  -  (1) 
Globlet cell  -  - 
Colon 
Crypt  cells  -  -,+i 
Cuticular  cell  -  (4)  -  (7) 
Globlet cells  -  - 
Mammary  gland 
Parenchyma  and  duct cells  -  (3)  -  (4) 
Lung  -  (3)  -  (4) 
Skin  -  (2)  -  (1) 
Testis  -  (3) 
Prostate  -  (4) 
Muscle  -  (2) 
A  single grading  indicates that all cases examined  showed the same degree 
of reactivity. 
*  -,  Three  of four cases; _,  one of four cases. 
* -,  Three  of four cases; +, one of four cases. 
0-, Six of seven cases; +, one of seven cases. 
Distribution of Antigens Defined by FH3 and FH4 Antibodies  in 
Gastrointestinal  Tissues of the Human Embryo 
The strongest expression of the antigens defined by FH3 and FH4 antibodies 
was found in stomach epithelia. The reactivity was intense in all cell populations 
of stomach epithelia at  35  d  of development (Fig.  1A  and B,  arrow a).  This 
intense reactivity continued up  to  90  d.  After  100  d,  the  reactivity of many 
stomach cell populations regressed, became limited to a deep layer at later stages 
(Fig.  1 C,  arrow  a),  and was finally limited to  the parietal  cells (Fig.  1D) and 
pyloric glands (data not shown) of newborn and adult gastric epithelia. The chief 
cells and other epithelial cells in stomach epithelia became completely negative 
in newborn and adult epithelia (Table IV, Fig.  1 D). 
Small intestinal epithelial cells were not stained by FH4 at 40 d of development 
(Fig.  1 A, arrow b), but were strongly stained by FH3 (Fig.  1 B, arrow b). At later 
stages, the majority of small intestine epithelial cells became negative; however, 
a strong reactivity with both  FH3 and FH4 was observed in some unidentified 
cells of fetal tissue (Fig.  1E). The antigens defined by both FH3 and FH4 in the 
majority of cell populations regressed subsequently, becoming restricted only to 512  FUCOSYL  TYPE  2  CHAIN  IN  HUMAN  EMBRYO  AND  CANCER FUKUSHI  ET  AL.  513 514  FUCOSYL  TYPE  2  CHAIN  IN  HUMAN  EMBRYO  AND  CANCER 
Paneth's  cells and  basal  granular  cells in  the  cryptic  region  of the  newborn  and 
adult  small intestine  (Fig.  1 F, arrow a; Table  IV). 
The  reactivity  of FH3  and  FH4  with  colonic  epithelial  cells showed  a  similar 
pattern.  These  cells  were  weakly  positive  in  the  early  embryo,  became  positive 
and  maximally  expressed  between  50  and  60  d  (Fig.  1 H,  arrow  a),  and  subse- 
quently  regressed.  At later  stages,  FH3  antigen  expression  was limited  to crypt 
cells  in  the  newborn  and  adult  (Fig.  1I,  arrow  a).  Crypt  cells  in  newborn  and 
adult  tissues  were not stained  by FH4  (data  not shown).  The  antigen  defined  by 
FH3  was present  in esophageal  epithelia  in the early fetus (Fig.  1 G) as well as in 
the  newborn  and  adult  (data  not  shown),  but  the  antigen  defined  by  FH4  was 
absent  in  esophageal  epithelia  throughout  all  stages of embryonic  development 
examined.  A  similar  distribution  was  found  in  the  fetal  pancreas;  the  ductal 
epithelium  was weakly stained  by FH3,  but not by FH4, and became completely 
negative  in  the  newborn.  It  is  interesting  to  note  that  the  antigen  defined  by 
FH3  was  present  in  cells  of  Langerhans'  islets,  but  that  defined  by  FH4  was 
absent  (data  not  shown).  Neither  antigen  was detected  in  the  various  stages  of 
liver development  (data  not shown). 
Respiratory Organs and Other Tissues 
The  epithelial  cells of trachea  and  secretory  glands  of bronchus  were  stained 
by FH3,  but not by FH4  in newborns.  No fetal tissue of bronchus  was available. 
The  epithelial  cells of the lung airway found  in fetal lung bud were positive with 
FH3, but were negative with FH4 (data not shown). The entire layer of epidermal 
tissue  of fetal  age  was positive  with  both  FH3  and  FH4,  but  the  reactivity  with 
FH4  became  negative  in  adult  tissue.  A  weakly  positive  reaction  was observed 
with  FH3  in  sebaceous  glands  and  in  ecrine  sweat  glands;  no  reactivity  was 
observed  with  FH4  (data  not  shown).  Heart,  aorta,  arteries,  veins,  cerebrum, 
cerebellum,  pons,  spinal  cord,  muscles,  and  bones  were  all  negative  with  both 
FH3 and  FH4  throughout  all developmental  stages (data not shown). 
FIGURE  1.  Staining of human gastrointestinal tissue at different stages of development and 
human  cancers by FH3 and FH4 antibodies.  (A) Paraffin-embedded section  of gastric and 
intestinal  tissue  of the  foregut of a  38-d-old  embryo stained with  FH4.  Arrow a  indicates 
gastric  epithelia. Arrow b indicates  intestinal  epithelia.  Note that only gastric epithelia are 
strongly stained. (B) The same section  as in A stained by FH3.  Note that both gastric and 
intestinal  epithelia are strongly stained.  (C) Paraffin-embedded section of gastric epithelia of 
120-d-old fetus stained by FH4. Only deep foveola are strongly stained (arrow a). (D) Frozen 
section  of adult gastric epithelia stained by FH4. None of the tissue is stained, except for the 
parietal cells (arrow a). (E) Paraffin-embedded section of intestinal  epithelia of 70-d-old  fetus 
stained by FH4. Many groups of cells, not identified exactly, are strongly stained, but unstained 
cells can also be seen.(F)  Paraffin-embedded section of newborn intestinal  epithelia stained by 
FH4. The majority of cells are negative and only Paneth's cells and basal granular cells (arrow 
a) are stained.  (G) Paraffin-embedded section  of esophagus tissue of 60-d-old embryo stained 
by FH3.  Positive  staining  is localized  in  the  solid  epithelial  area as indicated  by arrow  a 
(internal lumen of esophagus is not yet opened at this stage). The same section was not stained 
by FH4 (not shown). (H) Frozen section of colonic tissue of 50-d-old embryo stained by FH3. 
Only epithelial  tissue  (arrow a) is stained.  The same section  was not  stained by FH4 (not 
shown). (I) Frozen section  of adult colonic epithelia stained by FH3. Crypt cells (arrow a) are 
clearly stained.  The same section was not stained by FH4 (not shown). (jr) Frozen section from 
adenocarcinoma of colon stained by FH4. Stroma (a) is not stained.  (K) Frozen section  from 
infiltrative ductal carcinoma of breast stained by FH4. Only tumor cells (arrow a), but not 
stroma (b) are stained.  (L) Frozen section of tubular adenocarcinoma of stomach stained by 
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Distribution of the Antigen Defined by FH4 in Human Cancer in Comparison 
with Adult Normal Tissues 
Gastric cancer.  8 out of 1 1 cases of paraffin-embedded  sections and four out 
of five frozen  sections  of gastric  cancers  were strongly  or clearly  positive  with 
FH4 (Table V). All the positive cases were tubular or papillary adenocarcinoma, 
while all the negative cases were undifferentiated  adenocarcinoma  (Table V). A 
typical  positive example  is shown  in  Fig.  1 L.  In  normal  adult  gastric  epithelia, 
only  parietal  cells  and  pyloric  gland  cells  were  consistently  positive  in  both 
paraffin and frozen sections (Table IV). 
Colonic cancer.  Three  out of three  cases of paraffin-embedded  sections and 
seven out of eight cases of frozen sections were strongly or clearly positive with 
FH4 (Table  V). A  typical section  from colonic cancer is shown in  Fig.  1J.  Only 
one case was negative,  which was not correlated  with  the histological  character- 
istics of the case.  Normal  parts  of colonic epithelia  were all  negative,  including 
crypt cells in both paraffin and frozen sections, except for one case that showed 
a positive reaction  in the crypt cells. 
Breast cancer.  Three out of four cases of both paraffin-embedded  and frozen 
TABLE  V 
Reactivities of Human Cancers with FH4 Antibody 
Tumor tissue 
Reactivity (number of cases) 
Paraffin section  Frozen section 
Stomach cancer  Adenocarcinoma 
Colon cancer  Adenocarcinoma 
Ovary 
Testis 
Breasl 
Lung 
Gall bladder 
Prostate 
Skin 
Muscle 
++  (5/11)  ++  (2•5) 
+  (3/11)  +  (2•5) 
-  (4/1  1)  -  (1/5) 
++  (1/3)  ++  (5/8) 
+  (213)  +  (2•8) 
-  (013)  - 
Clear cell carcinoma 
Serous cystoadenocarcinoma 
Mucinary cystoadenocarcinoma 
Seminoma  -  (3/3) 
Infihrating ductal carcinoma  ++  (3/4) 
-  (1/4) 
Lymph node metastasis  ++  (2/2) 
Squamous cell carcinonla  -  (2/2) 
Adenocarcinoma 
Adenocarcinoma  -  (3/3) 
Benign adenoma  -  (3/3) 
Malignant melanoma  -  (1/1) 
teromnyosarcoma 
-  (111) 
-  (1/1) 
-  (111) 
++  (3/4) 
-  (114) 
++  (212) 
-  (4/4) 
+  (1/1) 
-  (111) 
-  (111) 
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sections of infiltrating ductal carcinoma were positive. A typical case is shown in 
Fig.  1 K. Metastatic lesions in lymph nodes were also strongly positive (Table V). 
Kidney cancer.  A great deal of variation in the staining of kidney tumors was 
observed, which  will  be described elsewhere. 3 These results may appropriately 
reflect the  normal  variation  in  the  reactivity of FH3 and  FH4 with  urogenital 
epithelia  during  their  development from  pronephros  to mesonephros  to meta- 
nephros (manuscript in preparation). 
Other cancers.  Various types of ovarial carcinoma, seminoma, lung squamous 
cell carcinoma, prostate adenocarcinoma,  malignant malanoma, and leiomyosar- 
coma were all negative. 
Discussion 
The reactivity of FH3 and FH4 with the developing human embryo and fetus 
can be summarized as follows: (a) The antigens detected by both FH3 and  FH4 
are  most  strongly  expressed  in  the  epithelial  cells  of the  gastrointestinal  and 
urogenital 3 organs at specific stages of development. Expression of these antigens, 
particularly  FH4,  regressed  upon  further  development  with  functional  differ- 
entiation,  and disappeared from most of the epithelial cell populations of those 
tissues with the exception of a  few specific types of cells in normal  adult tissue. 
(b) The antigen defined by FH3 appeared at an earlier stage of fetal development 
than the antigen defined by FH4; however, the antigen defined by FH4 regressed 
rapidly and completely at later stages of development and its expression became 
highly limited in adult epithelial tissues. The antigen defined by FH3 remained 
in a wider variety of cells than the antigen defined by FH4 in developed tissues. 
(c) In adult epithelial tissue, the antigen defined by FH4 was found to be limited 
to parietal  cells and pyloric glands of stomach epithelia,  Paneth's cells and basal 
granular  cells of the intestine,  and proximal convoluted tubules of the kidney. 3 
The antigen  was not detected by FH4 in the entire colonic epithelia,  including 
crypt cells. The crypt cells in colonic epithelia were positive with FH3.(d) A clear 
differential reactivity was found between the  FH3 and FH4 antibodies in seba- 
ceous  and  sweat  glands  of the  epidermis,  Langerhans'  islet  of the  pancreas, 
adrenal  medulla,  esophageal epithelia,  bronchial  epithelia, airway of lung buds, 
and  vaginal  epithelia.  Cells in  these  tissues were clearly or strongly stained  by 
FH3, but were not reactive with  FH4 throughout  fetal development as well as 
in newborn and adult tissues. 
The  antigens  defined  by  FH3  and  FH4  may  not  be  expressed  or  may  be 
expressed  weakly  in  preimplantation  human  embryos,  in  contrast  to  mouse 
embryos. This  possibility is suggested by the absence of SSEA-1  in  undifferen- 
tiated  human  teratocarcinoma  and  its  appearance  on  differentiation  (7),  in 
contrast to a  strong expression of SSEA-1  in  undifferentiated  mouse teratocar- 
cinoma and its decline on differentiation  (8,  12).  There were no cases in which 
tissues were negative at  fetal stages,  fblllowed by increasing expression  in  new- 
born or adult tissues. 
Maximum expression of the antigens defined by FH3 and FH4 was found in 
the epithelia  of tissues at  a  specific developmental  stage,  mostly 40-80  d.  This 
may  indicate  that  these  structures  are  essential  signals  for  cell  adhesion  and 
recognition, which could be an essential step for further differentiation  of fetal FUKUSHI  ET  AL.  517 
epithelial  cells into a  variety of functionally differentiated adult epithelial  cells. 
Despite our  lack of knowledge of a  functional  role of these structures,  such a 
dramatic  change,  with  maximum  expression  at  a  defined  stage  followed  by 
orderly disappearance, suggests a vital function for these structures in "chemical 
conversation" (23) between embryonic cells during epitheliogenesis. 
Since a  majority of human  cancers are derived front gastrointestinal,  urogen- 
ital,  and  pulmobronchial  epithelia,  in  which  X  or  oligomeric  X  antigens  are 
strongly expressed at embryonic to  fetal age, an  intense  reexpression  of these 
antigens  in a  large variety of human  cancers strongly suggests that these struc- 
tures  are  essentially  oncofetal  antigens.  Only  those  cancer  cells derived  front 
epithelial tissues that express a high level of these antigens during a certain stage 
of  development  showed  a  strong  reactivity  with  FH3  and  FH4  antibodies. 
Interestingly,  differentiated papillary adenocarcinoma of stomach expresses the 
antigen  defined  by  FH4,  whereas  undifferentiated  adenocarcinoma  does  not 
express  this  antigen.  Thus,  reexpression  of the  structure  defined  by  FH4  in 
tumors could be associated with retrogenesis of tumor cells to a certain stage of 
organogenesis rather than to a stage of the very early embryo. If retrogenesis of 
cells occurs to a  very early,  undifferentiated  stage of embryonic tissue,  tumor 
cells may not express the FH4 antigen (Fig. 2). 
Immunostaining  of both  X  antigen  and  multimeric  X  antigen  in  paraffin- 
embedded sections gave similar or identical results to those from immunostaining 
of frozen cryostat sections. This may indicate that (a) glycolipid antigens are not 
diminished  during  preparation  of paraffin  sections, or (b) the antigens  may be 
carried  by glycoproteins  that  are  not  diminished  by preparation  of paraffin 
sections.  Since many  lacto-series carbohydrates are carried  by both glycolipids 
and glycoproteins (24), it is reasonable to assume that the antigens detected by 
immunostaining of fetal tissue sections are, in fact, glycoproteins with properties 
similar to "embryoglycan" or lactosaminoglycans (25). 
Oncofetal expression  of both  FH3 and  FH4 should be based on a  common 
mechanism  for activation  of ~1  ---* 3  fucosyltransferase in  fetal epithelial  tissue 
and  in  certain  types of human  cancer.  The  fucosyltransferase that  makes FH4 
antigen  can  be distinguished  from  that  for  synthesis of FH3 antigen,  and  the 
genetic regulation  of these enzymes is a  crucial  mechanism  controlling  embry- 
ogenesis as well as oncogenesis. 
Summary 
Distribution  patterns  of specific fucose-containing  antigens  having  X  deter- 
minant  (Gal~31 ~  4[Fuco~l  ---*  3]GIcNAc)  as  well  as  the  di-  or  trimeric  X 
determinants  (Galfll  ---* 4[Fucal  ---> 3]GIcNAc31  ~  3Galfll  ~  4[Fuc~l  ---* 3]- 
GIcNAc) in the developing human embryo and fetus and in human cancer have 
been  examined  using  immunohistological  techniques.  Tissue  sections  were 
stained with monoclonal antibody FH3, which defines X  determinant,  and with 
monoclonal  antibody  FH4,  which  defines di-  or trimeric  X  determinant.  The 
following general trends in the expression of the antigens defined by FH3 and 
FH4 have been  observed: (a) A  well-organized,  orderly appearance and  disap- 
pearance of the antigens was observed during the histogenesis of various epithelia 
of gastrointestinal  and  other  organs.  The  developmental  stage  exhibiting  the 518  FUCOSYL  TYPE  2  CHAIN 
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FIGURE  2.  Stage-dependent expression of X antigen (defined by FH3) and di- or timeric X 
antigen (defined by FH4) in gastrointestinal epithelia during human development, and retro- 
genetic expression of the antigens in gastrointestinal tumors. X and di- or trimeric X antigens 
may not be expressed in preimplantation embryo, although the X antigen is highly expressed 
in mouse preimplantation embryo (8-10). This possibility is suggested by the absence of the 
X antigen in undifferentiated human teratocarcinoma and the induction of antigen synthesis 
on differentiation, which is the opposite of mouse teratocarcinoma (7). The antigens, however, 
are expressed in various tissues of human postimplantation embryos and fetuses. Curves a and 
c illustrate the change in FH4 antigen expression in gastric and colonic epithelia, respectively. 
Curve b represents the change in FH3 antigen expression in colonic epithelia. FH4 expression 
in colonic epithelia reaches its maximum between 7 and 9 wk, then regresses almost completely, 
while the FH3 antigen does not regress and remains in the crypt cells. The FH4 antigen is 
strongly expressed in differentiated gastric cancer, suggesting that antigen retrogenesis occurs 
to the point at which  FH4 expression is at its maximum (arrow 2). However, FH4 antigen 
expression is negative in undifferentiated gastric cancer because antigen retrogenesis occurs 
to a point at which FH4 is not yet expressed at the very early stages of embryogenesis (arrow 
1). Both FH3 and FH4 antigen expression in colonic cancer could be strong if retrogenesis of 
the antigen expression occurs to the point at which the FH3 antigen is active. The numbers 
at each stage of development represent the number of weeks  from  fertilization, g,  gastric 
epithelia; l, liver; i, intestine; c, colon. The ordinate indicates an arbitrary unit of antibody 
reactivity. 
maximum  antigen expression is different for each organ. (b) The  X  determinant 
defined  by  FH3  was expressed  ~2  wk earlier than  the  di- or trimeric  X  deter- 
minant defined by FH4, and the antigen defined by FH4 regressed more rapidly 
and  more  completely  than  the  X  determinant  defined  by  FH3  on  further 
development  of epithelial tissue. Thus,  expression of the  FH4  antigen is highly 
limited to specific types of cells in  newborn  and adult epithelial tissues.  (c) The 
antigen  defined by  FH4  was  strongly expressed  in  the  majority of tubular  and 
papillary adenocarcinoma  of stomach, adenocarcinoma  of colon, and infiltrating 
ductal  carcinoma  of breast and  its  metastatic  lesions.  No antigen  was  found  in 
poorly differentiated stomach  adenocarcinoma,  squamous  lung carcinoma, and 
many other  types of tumors  from  ovary,  testis, prostate,  skin,  and  muscle.  The FUKUSHI  ET  AL.  519 
presence of the antigen defined by FH4 is therefore limited to carcinoma of the 
stomach,  colon,  and breast  and  can  be  regarded  as a  retrograde  expression  of 
the antigen  to a  certain  stage  of fetal  development  in  which  expression  of this 
antigen was maximal. 
Received  for publication 26 March 1984. 
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